Showing results (361-370 of 569) with videos related to
Sort By:
Pageof 57
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2016
Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in OncologyWilliam J Gradishar, Benjamin O Anderson, Ron Balassanian, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2022
Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03)Erica L Mayer, Christian Fesl, Dominik Hlauschek, et al.Journal of the National Cancer Institute|March 24, 2010
Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survivalElizabeth M Azzato, Jonathan Tyrer, Peter A Fasching, et al.Human Molecular Genetics|April 26, 2012
Identification of a novel percent mammographic density locus at 12q24Kristen N Stevens, Sara Lindstrom, Christopher G Scott, et al.Oncotarget|August 29, 2015
SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survivalMaral Jamshidi, Rainer Fagerholm, Sofia Khan, et al.The New England Journal of Medicine|January 28, 2026
Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast CancerOtto Metzger, Sumithra Mandrekar, Shom Goel, et al.Journal of the National Cancer Institute|February 29, 2020
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51DXin Yang, Honglin Song, Goska Leslie, et al.Scientific Reports|April 28, 2018
E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association ConsortiumHisani N Horne, Hannah Oh, Mark E Sherman, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variantsHongyan Li, Christoph Engel, Miguel de la Hoya, et al.Breast Cancer Research and Treatment|December 17, 2008
No evidence that GATA3 rs570613 SNP modifies breast cancer riskSharon E Johnatty, Fergus J Couch, Zachary Fredericksen, et al.Pageof 57